Thanks John and good morning everyone. I will begin my overview on Slide 8 with first quarter highlights. Net sales increased 10% in the first quarter led by strong performance from debit and credit cards and continued growth in prepaid. The first quarter gross margin was impacted by negative sales mix and increased production costs, which resulted in adjusted EBITDA declining 8% in the quarter. We expect similar margin pressures in the second quarter before seeing improvement in the second half of the year, despite tariff impact, due to operating leverage and better mix especially in the fourth quarter. Free cash flow was slightly positive in the first quarter, as cash flow generated from operations was primarily utilized for capital spending, including our new Indiana production facility. Turning to the detailed first quarter results on Slide 9, the overall 10% sales increase reflected a 10% increase in both our debit and credit and prepaid segments. Debit and credit growth was led by contactless cards with strong growth from eco-focused cards, partially offset by a decline in personalization services. Prepaid growth was driven by continued strong demand for higher priced fraud prevention packaging solutions in our healthcare payment solutions. The gross profit margin decreased from 37.1% in the prior year quarter to 33.2%, as operating leverage from sales growth was offset by negative sales mix and increased production costs. Increased production costs reflect some operational inefficiencies, which we expect to diminish over the course of the year as well as incremental costs as we operate two production facilities in Indiana during our transition to the new site, SG&A, including depreciation and amortization, decreased almost $1 million from the prior year as the 2024 first quarter includes the final cost related to the prior CEO retention agreement and other executive severance. Net income decreased 12% primarily due to lower gross profit and higher interest expense, partially offset by lower operating expenses. Adjusted EBITDA decreased 8% to $21.2 million while adjusted EBITDA margin declined from 20.5% to 17.2% driven by the lower gross margin. Turning now to our segments on Slide 10, I discussed the segment sales drivers earlier so I will highlight segment profitability on this slide. Income from operations for the debit and credit segment decreased 5% in the first quarter as sales growth was offset by lower gross margins and increased operating expenses. Debit and credit gross margins increased compared to the fourth quarter but were impacted by sales mix and increased production costs compared to the prior year first quarter. Prepaid debit segment income from operations decreased 9% in the quarter, as benefits from sales growth were offset by lower gross margins, which were impacted by sales mix, including comparisons with a very strong margin in the first quarter of last year. Turning towards the balance sheet, liquidity and cash flow on Slide 11; we generated $5.6 million of cash from operating activities in the first quarter and invested $5.3 million in capital expenditures which resulted in free cash flow of $0.3 million. This compared to operating cash flow of $8.9 million and free cash flow of $7.4 million in the prior year. The decreased generation compared to the prior year was primarily due to an approximately $4 million increase in capital spending, which is supporting the buildout of our new Indiana secure card production facility. Cash flow was also impacted by lower net income excluding non-cash items and slightly higher working capital usage, including the impact of higher interest expense payments related to our senior note. On the balance sheet, at quarter end, we had $31.5 million of cash, no borrowings on our ABL revolver and $285 million of senior notes outstanding. Our net leverage ratio at quarter end was 3.1 times, up slightly from the 2024 year end levels of 3 times. Our capital structure and allocation priorities remain focused on investing in the business, including acquisitions such as Arroweye, deleveraging the balance sheet and returning funds to stockholders. Before we move on to our 2025 outlook, we have provided the latest US cards and circulation trends from Visa and MasterCard on Slide 12. For the three years ending December 31, cards in circulation in the US increased at 9% CAGR. Despite market uncertainties on the economic outlook and tariffs, the latest earnings reports from large bank issuers have continued to indicate strong account growth for card businesses, which is consistent with the customer demand we are seeing in the market. A change in the economic environment towards recessionary conditions could affect issuances and customer purchases, but at this point customer demand remains healthy. Turning now to our 2025 outlook on Slide 13; we have affirmed our organic net sales and adjusted EBITDA outlook, as we continue to expect mid to high single digit growth for both. The outlook does not include any contribution from the Arroweye acquisition and does not reflect any significant change in economic condition. It does include the impact of tariffs that have been put in place as well as cost savings activities we have recently undertaken to counter the pressures from first half mix issues and projected impacts from tariffs. Although our supply chain does not have material exposure to current tariff policies, we do procure some materials from China and Europe and currently project incremental costs of approximately $2 million, which is included in our outlook. We are making changes in our sourcing where possible to mitigate these tariff impacts. Semiconductor chips, our largest component in terms of value, are currently exempt from tariffs. Any change to remove the exemption or create a specific tariff for chips would likely impact our outlook. Arroweye will add to our expected sales and adjusted EBITDA for the remainder of the year and we will give more color on these expectations next quarter. Due to expected integration costs and some potential incremental CapEx to accelerate key Arroweye projects, we are not providing a free cash flow outlook this quarter. We do expect free cash flow to be lower than previously forecast due to these Arroweye items as well as timing of inventory purchases and tariff impacts on capital expenditures on the CPI business. Similarly, our net leverage ratio will be impacted by the Arroweye acquisition. Excluding Arroweye, we would still project the ratio to be below three times at year end, but financing the acquisition with cash and borrowing should temporarily move it above three times this year. We plan to work the ratio back down in 2026. We expect the impact to earnings per share from Arroweye to be dilutive in 2025 and slightly dilutive in 2026 due to integration and financing costs, before turning accretive in 2027. As noted in our press release, the purchase price for Arroweye was $45.55 million, which we funded using cash on the balance sheet and borrowings from our $75 million ABL revolving credit facility. We also anticipate being able to utilize around $5 million of Arroweye’s net operating loss tax benefits in the coming years. We will provide more insight on Arroweye’s expected impact in future quarters, but I will now pass the call back to John for some closing remarks on Slide 14. John?